跳至主要内容
临床试验/CTRI/2018/02/011851
CTRI/2018/02/011851已完成未知

Comparing the role of MRI, Gray scale and colour Doppler ultrasound in neoadjuvant chemotherapy response in breast cancer

Dr Rajinder Parshad0 个研究点目标入组 25 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Single palpable breast mass before chemotherapy
  • 2. Histologically proven case of breast cancer
  • 3. Patients with locally advanced breast cancer (T3/ T4 with any nodal status)
  • 4. Age of the patient 18 - 65 years
  • 5. Those who give informed written consent for the study

排除标准

  • 1. Patients who got <2 cycles of neoadjuvant chemotherapy
  • 2. Patients who completed 3 cycles of chemotherapy but not operated
  • 3. Patients lost to follow up or expired during or after NACT
  • 4. Patients with distant metastasis and recurrent breast cancer
  • 5. Patient not fit for neoadjuvant chemotherapy or MRI
  • 6. Multicentric or multifocal breast cancer

研究者

发起方
Dr Rajinder Parshad

相似试验